EUVIMEDEUVIMED entdecken
Crossref

Correction to “Pharmacokinetic and Pharmacodynamic Consequences of Liver‐Lung Crosstalk: Rethinking Dosing in Hepatopulmonary Syndrome and Portopulmonary Hypertension”

Comprehensive Physiology · 2026-12 · 16 (6)

DOI: 10.1002/cph4.70312 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Comprehensive Physiology, online erschienen am 03.11.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to “Pharmacokinetic and Pharmacodynamic Consequences of Liver‐Lung Crosstalk: Rethinking Dosing in Hepatopulmonary Syndrome and Portopulmonary Hypertension”. Comprehensive Physiology, 16(6). https://doi.org/10.1002/cph4.70312

Vancouver

Correction to “Pharmacokinetic and Pharmacodynamic Consequences of Liver‐Lung Crosstalk: Rethinking Dosing in Hepatopulmonary Syndrome and Portopulmonary Hypertension”. Comprehensive Physiology. 2026;16(6). doi:10.1002/cph4.70312

BibTeX
@article{euvimed2026,
  title = {Correction to “Pharmacokinetic and Pharmacodynamic Consequences of Liver‐Lung Crosstalk: Rethinking Dosing in Hepatopulmonary Syndrome and Portopulmonary Hypertension”},
  journal = {Comprehensive Physiology},
  year = {2026},
  volume = {16},
  number = {6},
  doi = {10.1002/cph4.70312}
}
Kostenlos starten →